CIK 0001906324
- Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- Operating
- EIN
- 874496285
- Phone
- +1 858-552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-28 | Busky Joseph M Chief Financial Officer | Shares withheld for taxes | −2,234 | $47.94 | $107K | 6,839 |
| 2024-03-28 | Busky Joseph M Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −4,925 | 9,850 | ||
| 2024-03-28 | Bujarski Robert Joseph Interim President, EVP & COO | Grant or award | +4,925 | 47,305 | ||
| 2024-03-28 | Bujarski Robert Joseph Interim President, EVP & COO | Shares withheld for taxes | −2,805 | $47.94 | $134K | 44,500 |
| 2024-03-28 | Bujarski Robert Joseph Interim President, EVP & COO | Exercise or conversion · Restricted Stock Units | −4,925 | 9,850 | ||
| 2024-03-28 | Kroll Werner SVP, Research & Development | Grant or award | +3,811 | 37,582 | ||
| 2024-03-28 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,801 | $47.94 | $86K | 35,781 |
| 2024-03-28 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −3,811 | 7,622 | ||
| 2024-03-28 | Hodges Michelle A. SVP, General Counsel | Grant or award | +2,462 | 14,320 | ||
| 2024-03-28 | Hodges Michelle A. SVP, General Counsel | Shares withheld for taxes | −879 | $47.94 | $42K | 13,441 |
| 2024-03-28 | Hodges Michelle A. SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −2,462 | 4,926 | ||
| 2024-02-27 | Iskra Michael S. Interim CEO, EVP & CCO | Grant or award · Restricted Stock Units | +21,367 | 21,367 | ||
| 2024-02-27 | Busky Joseph M Chief Financial Officer | Grant or award · Restricted Stock Units | +21,367 | 21,367 | ||
| 2024-02-27 | Bujarski Robert Joseph Interim President, EVP & COO | Grant or award · Restricted Stock Units | +21,367 | 21,367 | ||
| 2024-02-23 | Busky Joseph M Chief Financial Officer | Purchase | +2,150 | $46.36 | $100K | 2,150 |
| 2024-02-14 | Brandy Louise SVP, Chief Information Officer | Shares withheld for taxes | −194 | $45.27 | $9K | 1,233 |
| 2024-02-14 | Brandy Louise SVP, Chief Information Officer | Exercise or conversion · Restricted Stock Units | −473 | 947 | ||
| 2024-02-10 | Bujarski Robert Joseph EVP & COO | Grant or award | +1,052 | 42,820 | ||
| 2024-02-10 | Bujarski Robert Joseph EVP & COO | Shares withheld for taxes | −575 | $68.15 | $39K | 42,245 |
| 2024-02-10 | Bujarski Robert Joseph EVP & COO | Grant or award | +315 | 42,560 |
Page 27 of 33 · 642 trades